MiMedx Group, a major supplier to government-run hospitals, has said its products help heal wounded service members and veterans, however the company limited the range of products it offered to federal buyers forcing the government to purchase more costly products than it needed for common treatments, the Wall Street Journal reports, citing former employees and company product lists. The company, which manufactures skin grafts and injectable products from placental tissues, has faced headwinds this year including restating financial results since 2012, ousting founder and former CEO Parker Petit and facing investigations into its practices by the Justice Department, the Department of Veterans Affairs and the Securities and Exchange Commission.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.